IntroductionT cell independent type-1 (TI-1) antigens, such as lipopolysaccharide (LPS), are intrinsically stimulatory for B cells [1][2][3][4][5][6] . However, antibodies made in response to these antigens are antigen specific. 1,7 This specificity is thought to be achieved through specific B cell Ig receptors binding to epitopes within the TI-1 antigen, leading to the focusing of the non-specific stimulatory signals to the surface of antigenspecific cells. 5,6,8,9 When high concentrations of LPS are focused to the B cell surface by surface (s)Ig, however, the specific response is inhibited. Coutinho and Möller's one-signal model assumed that this inhibition was due to high-dose paralysis, 9 a phenomenon that our accompanying paper disputes.10 As an alternative, we have proposed the hypothesis that the inhibition of ASC formation at high concentrations is due to B cells receiving a sIg-mediated signal at the same time as the TI-1 activation signal.11 This alternative hypothesis, and not that of Coutinho and Möller, is consistent with the ability of anti-Ig reagents to inhibit LPS-induced antibody secreting cell (ASC) formation.
12-15The important point of difference between the two models is that in one an antigen signal transmitted by sIg is not involved, whereas in the other this signal is essential.One potential way to distinguish experimentally between our model and that described by Coutinho and Möller 9 was to measure the hapten-specific dose-response curves in the presence of an inhibitor of the sIg-mediated antigen signal that does not also affect LPS stimulation. If our model is correct, the curve would convert from being bell shaped to being conventionally sigmoidal. In contrast, the Coutinho and Möller model would expect no change to the dose curve. A possible candidate for an inhibitory drug with these characteristics was cyclosporine A (CsA), because this drug has been shown in vitro to inhibit sIg-mediated signals, but not LPS-induced B cell responses, over a broad concentration range. [16][17][18] To examine whether CsA could be used in this way, it was important to first show that this drug would prevent the ability of anti-Ig reagents to inhibit LPS-induced ASC formation, as originally shown by Andersson et al. 12 Experiments that set out to test this possibility are described below.
Materials and Methods
Experimental animalsB cells were prepared from CBA/H mice aged between 6 and 14 weeks. Mice were obtained and housed at the animal facility at the John Curtin School of Medical Research (Canberra, ACT, Australia). Summary An antigen-specific B cell response can be induced by low concentrations of haptenated lipopolysaccharide (LPS), whereas high concentrations are inhibitory. Two explanations have been proposed for the latter phenomenon. In the first, specific surface Ig focuses LPS to the B cell membrane, where high local concentrations of the mitogen become paralytic for B cell responses. In the alternative, transmission of an antigen signal at higher concentrations of hapten LPS active...